Menu

Question 3301

Topic: Biology, Genetics & Bone Healing

In a patient presenting with aseptic loosening 10 years after an uncemented total hip arthroplasty, the primary driver of periprosthetic osteolysis is the activation of macrophages. Which signaling molecule is ultimately overexpressed by these cells to induce bone resorption?

. Osteoprotegerin (OPG)
. Bone morphogenetic protein-7 (BMP-7)
. Transforming growth factor-beta (TGF-b)
. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Interleukin-10 (IL-10)

Correct Answer & Explanation

. Receptor activator of nuclear factor kappa-B ligand (RANKL)


Explanation

Phagocytosis of polyethylene wear debris by macrophages stimulates the release of pro-inflammatory cytokines like TNF-alpha and IL-1. This leads to the overexpression of RANKL, which drives osteoclast differentiation and subsequent periprosthetic osteolysis.

Question 3302

Topic: Biology, Genetics & Bone Healing

A 32-year-old female presents with a destructive, eccentrically located lytic lesion in the distal femur epimetaphysis. Biopsy confirms a Giant Cell Tumor of bone. If medical therapy is considered, denosumab may be used. What is its specific mechanism of action?

. Inhibits the formation of the RANK/RANKL complex
. Directly induces apoptosis of the neoplastic mononuclear cells
. Inhibits vascular endothelial growth factor (VEGF)
. Binds directly to osteoclasts to inhibit their ruffled border formation
. Promotes osteoblast differentiation via Wnt signaling

Correct Answer & Explanation

. Inhibits the formation of the RANK/RANKL complex


Explanation

Denosumab is a monoclonal antibody that binds to RANKL, preventing it from binding to the RANK receptor on the surface of osteoclast precursors. This inhibits the recruitment and activation of the reactive multinucleated giant cells responsible for the aggressive osteolysis in Giant Cell Tumors.

Question 3303

Topic: Biology, Genetics & Bone Healing

Which of the following best describes the intracellular signaling pathway utilized by Bone Morphogenetic Protein-2 (BMP-2) after it binds to its cell surface receptor?

. Activation of JAK/STAT signaling pathway
. Activation of the SMAD 1, 5, 8 complex
. Inhibition of the Wnt/beta-catenin pathway
. Activation of the SMAD 2, 3 complex
. Direct phosphorylation of RUNX2 by a tyrosine kinase

Correct Answer & Explanation

. Activation of the SMAD 1, 5, 8 complex


Explanation

BMPs (such as BMP-2 and BMP-7) bind to serine/threonine kinase receptors on the cell surface. This binding leads to the intracellular phosphorylation and activation of receptor-regulated SMADs, specifically SMADs 1, 5, and 8. These then form a complex with the co-SMAD (SMAD 4) to translocate into the nucleus and upregulate osteogenic genes like RUNX2. SMADs 2 and 3 are typically activated by TGF-beta, not BMPs.

Question 3304

Topic: Biology, Genetics & Bone Healing

A 32-year-old female is diagnosed with an advanced, surgically unresectable giant cell tumor (GCT) of the sacrum. Her oncologist recommends medical therapy with Denosumab to halt disease progression. What is the primary molecular target of this monoclonal antibody?

. Osteoprotegerin (OPG)
. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Vascular endothelial growth factor (VEGF)
. Colony-stimulating factor 1 receptor (CSF1R)
. Tumor necrosis factor-alpha (TNF-alpha)

Correct Answer & Explanation

. Receptor activator of nuclear factor kappa-B ligand (RANKL)


Explanation

Denosumab is a fully human monoclonal antibody that binds to and inhibits RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand). In Giant Cell Tumor of bone, the neoplastic mononuclear stromal cells overexpress RANKL, which aggressively recruits and activates the reactive multinucleated giant cells (osteoclast-like cells) responsible for massive bone destruction. Blocking RANKL effectively arrests the osteolysis and tumor progression.

Question 3305

Topic: Biology, Genetics & Bone Healing

A 72-year-old man with increasing hat size and bowing of his femurs is diagnosed with Paget's disease. The primary cellular defect in this condition is characterized by:

. A primary defect in osteoblast mineralization
. Excessive proliferation of atypical chondrocytes
. Overactive osteoclasts with an increased number of nuclei
. An absence of functional ruffled borders on osteoclasts
. Deficient production of type I collagen by fibroblasts

Correct Answer & Explanation

. Overactive osteoclasts with an increased number of nuclei


Explanation

Paget's disease of bone is driven by a primary abnormality in osteoclasts. These cells are massively enlarged, overactive, and multinucleated (sometimes containing up to 100 nuclei per cell, often with paramyxovirus-like inclusion bodies). This intense resorptive phase is followed by chaotic, disorganized osteoblastic bone formation.

Question 3306

Topic: Biology, Genetics & Bone Healing

A 45-year-old female presents with diffuse, dull bone pain and proximal muscle weakness. Laboratory studies reveal low serum calcium, low serum phosphorus, elevated alkaline phosphatase, and elevated parathyroid hormone (PTH) levels. What is the most likely diagnosis?

. Osteoporosis
. Osteomalacia
. Paget's disease
. Primary hyperparathyroidism
. Renal osteodystrophy

Correct Answer & Explanation

. Osteomalacia


Explanation

The laboratory profile of low calcium, low phosphorus, high alkaline phosphatase, and high parathyroid hormone (secondary hyperparathyroidism) is the classic hallmark of osteomalacia, most commonly due to severe Vitamin D deficiency. Osteoporosis typically features normal lab values. Primary hyperparathyroidism presents with high calcium.

Question 3307

Topic: Biology, Genetics & Bone Healing
Osteoclasts tightly adhere to the bone surface to form a sealed resorptive microenvironment. This attachment is primarily mediated by the binding of which integrin to the RGD (Arg-Gly-Asp) sequence found in bone matrix proteins like osteopontin?
. Integrin alpha-5 beta-1
. Integrin alpha-v beta-3
. Integrin alpha-2 beta-1
. Integrin alpha-L beta-2
. Integrin alpha-M beta-2

Correct Answer & Explanation

. Integrin alpha-v beta-3


Explanation

The αvβ3 integrin is heavily expressed on the surface of osteoclasts. It binds to RGD (arginine-glycine-aspartic acid) sequences in non-collagenous bone matrix proteins such as osteopontin and bone sialoprotein. This binding is essential for creating the sealing zone required for effective ruffled border function and bone resorption.

Question 3308

Topic: Biology, Genetics & Bone Healing

A 4-year-old child presents with gingival bleeding, petechiae, and bone pain. Radiographs reveal generalized osteopenia and a dense zone of provisional calcification (white line of Frankel). The child is diagnosed with scurvy. The underlying pathophysiologic defect is a failure of:

. Mineralization of osteoid by osteoblasts
. Hydroxylation of proline and lysine residues
. Cleavage of procollagen to tropocollagen
. Cross-linking of tropocollagen molecules by lysyl oxidase
. Transcription of the COL1A1 gene

Correct Answer & Explanation

. Hydroxylation of proline and lysine residues


Explanation

Scurvy is caused by Vitamin C (ascorbic acid) deficiency. Vitamin C is an essential cofactor for the enzymes prolyl hydroxylase and lysyl hydroxylase. Failure to hydroxylate proline and lysine residues prevents the proper formation of the procollagen triple helix, resulting in defective Type I collagen.

Question 3309

Topic: Biology, Genetics & Bone Healing

Denosumab is used in the treatment of osteoporosis and giant cell tumor of bone. Which of the following best describes its mechanism of action?

. It binds to the ruffled border of osteoclasts, disrupting the proton pump
. It competitively inhibits the binding of parathyroid hormone to its receptor
. It acts as a monoclonal antibody against RANKL, preventing RANK activation
. It stimulates the Wnt signaling pathway via sclerostin inhibition
. It incorporates into the bone matrix and induces osteoclast apoptosis upon ingestion

Correct Answer & Explanation

. It acts as a monoclonal antibody against RANKL, preventing RANK activation


Explanation

Denosumab is a fully human monoclonal antibody that binds to Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). By binding RANKL, it prevents RANKL from interacting with the RANK receptor on osteoclasts and their precursors, thereby profoundly inhibiting osteoclast formation, function, and survival.

Question 3310

Topic: Biology, Genetics & Bone Healing

When a massive cortical bone allograft is utilized for reconstruction, it undergoes incorporation via a process called creeping substitution. Which of the following best describes the initial cellular event in the incorporation of a cortical graft?

. Appositional new bone formation directly on the graft surface by osteoblasts
. Rapid vascular ingrowth facilitated by existing allograft vessels
. Osteoclastic resorption leading the cutting cone
. Differentiation of allograft mesenchymal stem cells into osteocytes
. Immediate transformation into woven bone via endochondral ossification

Correct Answer & Explanation

. Osteoclastic resorption leading the cutting cone


Explanation

Cortical bone grafts incorporate via creeping substitution, which begins with osteoclastic resorption. Osteoclasts bore out 'cutting cones' into the Haversian systems of the necrotic graft bone. This is followed closely by osteoblasts laying down new bone. Conversely, cancellous bone grafts initially undergo appositional new bone formation on the trabecular surfaces before significant resorption occurs.

Question 3311

Topic: Biology, Genetics & Bone Healing

Osteopetrosis is a rare genetic disorder characterized by dense, brittle bones due to impaired osteoclast function. A common mutation responsible for the autosomal recessive infantile form affects the enzyme Carbonic Anhydrase II. What is the normal function of this enzyme in the osteoclast?

. It synthesizes Cathepsin K for matrix degradation
. It generates protons (H+) to acidify the clear zone at the ruffled border
. It acts as a receptor for RANKL on the osteoclast membrane
. It facilitates the apoptosis of osteoclasts to limit bone resorption
. It produces tartrate-resistant acid phosphatase (TRAP)

Correct Answer & Explanation

. It generates protons (H+) to acidify the clear zone at the ruffled border


Explanation

In the osteoclast, Carbonic Anhydrase II catalyzes the conversion of CO2 and H2O into carbonic acid, which dissociates into protons (H+) and bicarbonate. The protons are pumped across the ruffled border via vacuolar H+-ATPases to acidify the resorption pit (Howship's lacuna), which dissolves bone mineral. Deficient CA II prevents this acidification, leading to non-functional osteoclasts and osteopetrosis.

Question 3312

Topic: Biology, Genetics & Bone Healing

Bone Morphogenetic Proteins (BMPs) are members of the TGF-beta superfamily and are potently osteoinductive. Upon binding to their transmembrane cell-surface receptors, which intracellular signaling molecules are directly phosphorylated to translocate to the nucleus and initiate transcription of osteogenic genes?

. JAK and STAT
. Beta-catenin and TCF/LEF
. Smad 1, 5, and 8
. cAMP and PKA
. Ras and MAP kinase

Correct Answer & Explanation

. Smad 1, 5, and 8


Explanation

BMPs bind to serine/threonine kinase receptors on the cell surface. This binding phosphorylates intracellular receptor-regulated Smads (R-Smads), specifically Smad 1, 5, and 8. These phosphorylated R-Smads then form a complex with the common-partner Smad (Co-Smad 4) and translocate into the nucleus to regulate the transcription of target osteogenic genes.

Question 3313

Topic: Biology, Genetics & Bone Healing

Fibrous dysplasia is a benign developmental anomaly of bone characterized by the replacement of normal cancellous bone with immature fibrous tissue and poorly formed woven bone ('Chinese character' trabeculae). The somatic mosaic mutation responsible for this condition occurs in the GNAS1 gene. What is the physiological consequence of this mutation?

. Inactivation of the Wnt/beta-catenin pathway
. Constitutive activation of the Gs-alpha protein, leading to increased intracellular cAMP
. Inhibition of the RANKL-OPG axis, preventing osteoclast formation
. Defect in the mineralization of newly formed osteoid
. Overproduction of basic Fibroblast Growth Factor (bFGF)

Correct Answer & Explanation

. Constitutive activation of the Gs-alpha protein, leading to increased intracellular cAMP


Explanation

Fibrous dysplasia and McCune-Albright syndrome are caused by an activating missense mutation in the GNAS1 gene. This gene encodes the alpha subunit of the stimulatory G protein (Gs). The mutation causes constitutive activation of adenylate cyclase, leading to inappropriately high intracellular levels of cyclic AMP (cAMP). This excessive cAMP signaling drives the abnormal proliferation and differentiation of skeletal progenitor cells.

Question 3314

Topic: Biology, Genetics & Bone Healing
During the process of secondary fracture healing, what is the primary collagen type synthesized by chondrocytes during the soft callus phase?
. Type I collagen
. Type II collagen
. Type III collagen
. Type IX collagen
. Type X collagen

Correct Answer & Explanation

. Type II collagen


Explanation

During the soft callus phase of endochondral ossification, proliferating chondrocytes predominantly produce Type II collagen to form a cartilaginous template. As the matrix calcifies later, hypertrophic chondrocytes express Type X collagen before it is replaced by Type I collagen.

Question 3315

Topic: Biology, Genetics & Bone Healing

A 45-year-old male undergoes open reduction and internal fixation of a transverse radial shaft fracture using a dynamic compression plate, achieving absolute stability. Which of the following best describes the primary mode of bone healing expected in this scenario?

. Endochondral ossification with callus formation
. Intramembranous ossification with primary bone healing
. Cartilage intermediate replacement
. Fibrous tissue calcification
. Secondary bone healing driven by micromotion

Correct Answer & Explanation

. Intramembranous ossification with primary bone healing


Explanation

Rigid internal fixation with absolute stability (e.g., dynamic compression plating) eliminates micromotion at the fracture site. This leads to primary bone healing via cutting cones and direct Haversian remodeling without the formation of an intermediate fracture callus.

Question 3316

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) induce osteoblastic differentiation of mesenchymal stem cells. Which of the following intracellular signaling pathways is primarily responsible for mediating this osteoinductive effect?

. Wnt/beta-catenin
. Smad 1/5/8
. MAPK/ERK
. JAK/STAT
. Notch/Hes

Correct Answer & Explanation

. Smad 1/5/8


Explanation

BMPs bind to serine-threonine kinase receptors, leading to phosphorylation of Smad 1, 5, and 8. These complex with Smad 4 to translocate to the nucleus and upregulate osteogenic genes like Runx2.

Question 3317

Topic: Biology, Genetics & Bone Healing

A 32-year-old female presents with an expansile, eccentric lytic lesion in the distal femur epimetaphysis. Biopsy confirms Giant Cell Tumor of bone (GCT). She is treated with denosumab preoperatively to consolidate the tumor margins. Denosumab targets which of the following mechanisms?

. Inhibition of vascular endothelial growth factor (VEGF)
. Direct apoptosis of the neoplastic mononuclear stromal cells
. Binding to RANK-Ligand to prevent osteoclast activation
. Blockade of the Wnt signaling pathway
. Inhibition of matrix metalloproteinases (MMPs)

Correct Answer & Explanation

. Binding to RANK-Ligand to prevent osteoclast activation


Explanation

Denosumab is a monoclonal antibody that binds to RANK-Ligand (RANKL), preventing it from activating RANK on the surface of osteoclasts and their precursors. In GCT, the neoplastic stromal cells overexpress RANKL, driving the massive osteoclast-mediated bone destruction.

Question 3318

Topic: Biology, Genetics & Bone Healing

Which of the following mechanical environments most strongly drives secondary bone healing (endochondral ossification) rather than primary bone healing in fracture repair?

. Absolute stability with strain < 2%
. Interfragmentary strain rate between 2-10%
. Fracture gap size < 0.1 mm
. Rigid plate fixation with compression
. Strain rate > 15%

Correct Answer & Explanation

. Interfragmentary strain rate between 2-10%


Explanation

Secondary bone healing via callus formation is promoted by a mechanical environment with intermediate strain, typically between 2% and 10%. Absolute stability (strain < 2%) promotes primary (Haversian) bone healing, while strain > 10% typically leads to nonunion.

Question 3319

Topic: Biology, Genetics & Bone Healing

Denosumab, a monoclonal antibody used in the treatment of osteoporosis and giant cell tumors of bone, exerts its primary effect by binding to and inhibiting which of the following targets?

. Sclerostin
. RANK ligand
. Cathepsin K
. Osteoprotegerin
. Parathyroid hormone receptor

Correct Answer & Explanation

. RANK ligand


Explanation

Denosumab binds to and inhibits RANK ligand (RANKL), preventing it from activating the RANK receptor on osteoclasts. This blockade severely decreases osteoclast differentiation, function, and survival, leading to a marked reduction in bone resorption.

Question 3320

Topic: Biology, Genetics & Bone Healing

Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) is utilized extensively in spine fusion and complex fracture nonunions to promote osteogenesis. Upon binding to its specific serine/threonine kinase cell surface receptor, which primary intracellular signaling pathway does rhBMP-2 activate?

. Wnt/beta-catenin pathway
. Mitogen-activated protein (MAP) kinase pathway
. Smad 1/5/8 signaling pathway
. Janus kinase/signal transducers and activators of transcription (JAK-STAT) pathway
. Notch/Delta signaling pathway

Correct Answer & Explanation

. Smad 1/5/8 signaling pathway


Explanation

Bone Morphogenetic Proteins (BMPs) initiate intracellular signaling by binding to specific cell surface receptors, which subsequently phosphorylate and activate the Smad 1/5/8 complex. These activated Smads then partner with Smad 4, translocating into the nucleus to drive the transcription of osteogenic genes.